colon cancer
Conditions
Interventions
None listed
Sponsors
Saitama Medical University International medical center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed with primary colorectal cancer 2) Patients who are 20 years of age or older at the time of consent 3) Patients whose gastrointestinal surgeon determines that surgical therapy is necessary 4) Patients whose written consent for this study has been obtained 5) Patients who will undergo ileal resection or right hemicolectomy of the colon for right-sided colorectal cancer or left hemicolectomy, descending colon resection, or sigmoid colon resection for left-sided colorectal cancer
Exclusion criteria
Exclusion criteria: 1) Patients with multiple cancers 2) Patients with a history of autoimmune bowel disease 3) Patients with a history of severe hepatic dysfunction 4) Patients with a history of severe renal dysfunction 5) Patients receiving antimicrobial agents on a regular basis 6) Patients who received preparations that affect intestinal bacteria such as intestinal antiflatulents and probiotics preoperatively. 7) Patients who receive chemotherapy (antimetabolites, platinum, molecular-targeted drugs, immune checkpoint inhibitors) preoperatively and postoperatively. 8) Patients who receive chemotherapy (antimetabolite, platinum, molecular-targeted drug, immune checkpoint inhibitor) before and after surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pre- and postoperative voiding function | — |
Secondary
| Measure | Time frame |
|---|---|
| Pre- and postoperative intestinal flora | — |
Countries
Japan
Contacts
Public ContactSohei Akuta
Saitama Medical University International medical center Gastrointestinal Surgery
Outcome results
None listed